Eisler Capital (Uk) Ltd. Bristol Myers Squibb CO Call Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $683,936 - $892,428	-17,245 Reduced 8.4%	187,936 $9.73 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $2.15 Million - $2.83 Million	53,430 Added 35.21%	205,181 $8.52 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $3.04 Million - $3.45 Million	63,402 Added 71.76%	151,751 $8.23 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $3.49 Million - $4.17 Million	72,041 Added 441.75%	88,349 $4.53 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $944,070 - $1.06 Million	16,308 New	16,308 $946,000

2,537

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.